Dare Bioscience, Inc. (DARE) Financials
DARE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 25.1 million | 27.3 million |
2023-06-30 | 23.2 million | 25.9 million |
2023-03-31 | 30.4 million | 25.4 million |
2022-12-31 | 43.8 million | 32.7 million |
DARE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.0 million | 636086 |
2023-06-30 | -6.6 million | 650186 |
2023-03-31 | -16.1 million | 624621 |
2022-12-31 | -5.9 million | 532133 |
DARE Net Income
No data available :(
DARE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 13.9 million | - | 194586 |
2023-06-30 | 13.3 million | - | 295151 |
2023-03-31 | 19.8 million | - | 392892 |
2022-12-31 | 34.7 million | - | 488737 |
DARE Shares Outstanding
DARE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 22099 | 6.7 million | 2.7 million | - |
2023-06-30 | - | 6.0 million | 2.9 million | - |
2023-03-31 | - | 5.0 million | 3.4 million | - |
2022-12-31 | 2697 | 13.0 million | 3.2 million | - |
DARE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.0 million | 9260 |
2023-06-30 | - | 9615 |
2023-03-31 | - | 3602 |
2022-12-31 | 10.0 billion | 4717 |
DARE
Price: $0.31
52 week price:
Earnings Per Share: -0.35 USD
P/E Ratio: -0.74
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 48.3 million